Bicycle Therapeutics plc

BCYC | NASDAQ | 3 Sledující

$8.22

-5.52%

-$0.48

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 USD	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	35,275 +30.76%	26,976 +86.52%	14,463 +23.65%	11,697 -
Cost of revenue	0 -100.00%	6,467 +75.41%	3,687 -91.79%	44,880 -
Gross profit	35,275 +72.00%	20,509 +90.32%	10,776 +132.48%	-33,183 -
Operating expense	245,147 +13.01%	216,922 +65.44%	131,116 +69.59%	77,315 -
Operating income	-209,872 -10.49%	-189,946 -62.83%	-116,653 -77.78%	-65,618 -
Pretax Income	-173,796 +3.02%	-179,207 -56.87%	-114,241 -66.82%	-68,482 -
Tax Provision	-4,765 -427.04%	1,457 +195.60%	-1,524 +8.36%	-1,663 -
Net income	-169,031 +6.44%	-180,664 -60.28%	-112,717 -68.69%	-66,819 -
EPS	-0.29 +94.29%	-5.08 -33.68%	-3.8 -42.32%	-2.67 -
Diluted EPS	-0.29 +94.29%	-5.08 -33.68%	-3.8 -42.32%	-2.67 -
Average Shares	582,076 +1,535.40%	35,592 +20.00%	29,661 +18.35%	25,062 -
Diluted Average Shares	582,076 +1,535.40%	35,592 +20.00%	29,661 +18.35%	25,062 -
EBIT	-172,066 +2.20%	-175,944 -50.83%	-116,653 -78.10%	-65,498 -
EBITDA	-164,892 +10.09%	-183,400 -62.35%	-112,964 -76.28%	-64,081 -

Soubory cookie používáme ke zlepšení prohlížení na webu.